AcouSort delivers AcouTrap system to Karolinska Institutet as part of the successful IndiCell project
In 2021, AcouSort AB (publ) (”AcouSort”, “the Company”) received funding from Vinnova for the
project IndiCell. The aim of the project is to enable the transfer of novel stem cell treatments from
research to a clinical setting. The project is planned to run over five years and generate revenues of
SEK 1.25 million to AcouSort. AcouSort has now finalized the application development and has
installed an AcouTrap system at Karolinska Institutet, where it will be used to automate the
isolation and wash of stem cells.
As part of the project, AcouSort has developed methods on the AcouTrap system for isolation and wash of
stem cells before they are used in injections. The application development part is now finalized, and as part of
the project an AcouTrap system has been installed at Karolinska Institutet, one of the consortium partners. The
system will be used throughout the rest of the project to automate the isolation and wash of stem cells used in
the research efforts to develop new stem cell-based therapies.
“The IndiCell project is a great example of how the AcouTrap can be used to automate cell sample preparation
workflows and we are very happy to see how the recent update of AcouTrap has proven to be valuable in the
development of new stem cell-based therapies,” says AcouSort’s Commercial Director Agnes Michanek.
